Inflammatory Bowel Disease

Top Story

Real-world Crohn’s study shows genetic link to immunogenicity, biosimilar equivalence

February 21, 2018
Meeting News

Age, immunomodulator use increase cancer risk in IBD patients

February 20, 2018
Older patients with inflammatory bowel disease who have recently taken immunomodulators were more likely to have or develop cancer, according to research presented at…
In the Journals

Best practice update: GI psychologists, GIs need collaboration

February 20, 2018
Gastroenterologists should play an important role in the promotion of psycho-gastroenterology therapy, and research and clinical gaps need to be addressed to effectively…
Meeting News

Oral JAK1 inhibitor upadacitinib maintains response in Crohn’s through 1 year

February 19, 2018
Many patients with Crohn’s disease who responded to upadacitinib in the induction phase of the phase 2 CELEST study maintained response through 1 year in the…
More Headlines »

Highlights of the IBD Summit for Fellows

This activity is supported by independent educational grants from AbbVie; Pfizer; Salix Pharmaceuticals; and Takeda Pharmaceutical U.S.A., Inc.

Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3…
More »
GI Bookshelf

Chapter 14: Nutrition In The Elderly

From Clinical Nutrition in Gastrointestinal Disease
More »
Resource Centers
Meeting News

VIDEO: Expert discusses cases of hepatitis E, PSC in patients with IBD

November 14, 2017
More »